Haddock Jason
CFO at ARRAY BIOPHARMA INC
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 7, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARRAY BIOPHARMA INCPlan not statedJan 16 2018
Sold 7,500 shares at $13.73 ($103k)
Haddock Jason, CFO
Sold 20.6% of holdings ($499k position)28,868 shares leftFirst sale on recordFiling
- 2 Form 4 sale ARRAY BIOPHARMA INCUnusualJul 30 +195 days
Sold 25,000 shares at $14.87 ($372k)
Haddock Jason, CFO
Sold 31.1% of holdings ($1.2M position)55,393 shares leftFiling
- 3 Form 4 sale ARRAY BIOPHARMA INCUnusualAug 15 +16 days
Sold 20,000 shares at $13.92 ($278k)
Haddock Jason, CFO
Sold 36.1% of holdings ($771k position)35,393 shares leftFiling
- 4 Form 4 sale ARRAY BIOPHARMA INCUnusualFeb 7 +176 days
Sold 96,712 shares at $21.80 ($2.1M)
Haddock Jason, CFO
Sold 76.3% of holdings ($2.8M position)30,059 shares left4.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2019 | ARRAY BIOPHARMA INC | CFO | Form 4 sale | 96,712 | $2.1M | 76.3% | Unusual | SEC |
| Aug 15, 2018 | ARRAY BIOPHARMA INC | CFO | Form 4 sale | 20,000 | $278k | 36.1% | Unusual | SEC |
| Jul 30, 2018 | ARRAY BIOPHARMA INC | CFO | Form 4 sale | 25,000 | $372k | 31.1% | Unusual | SEC |
| Jan 16, 2018 | ARRAY BIOPHARMA INC | CFO | Form 4 sale | 7,500 | $103k | 20.6% | Plan not stated | SEC |